» Articles » PMID: 27757062

Individual Variation in Functional Brain Connectivity: Implications for Personalized Approaches to Psychiatric Disease

Overview
Specialty Neurology
Date 2016 Oct 21
PMID 27757062
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Functional brain connectivity measured with functional magnetic resonance imaging (fMRI) is a popular technique for investigating neural organization in both healthy subjects and patients with mental illness. Despite a rapidly growing body of literature, however, functional connectivity research has yet to deliver biomarkers that can aid psychiatric diagnosis or prognosis at the single-subject level. One impediment to developing such practical tools has been uncertainty regarding the ratio of intra- to interindividual variability in functional connectivity; in other words, how much variance is state- versus trait-related. Here, we review recent evidence that functional connectivity profiles are both reliable within subjects and unique across subjects, and that features of these profiles relate to behavioral phenotypes. Together, these results suggest the potential to discover reliable correlates of present and future illness and/or response to treatment in the strength of an individual's functional brain connections. Ultimately, this work could help develop personalized approaches to psychiatric illness.

Citing Articles

Brain-Cognition Fingerprinting via Graph-GCCA with Contrastive Learning.

Wang Y, Peng W, Zhang Y, Adeli E, Zhao Q, Pohl K Mach Learn Clin Neuroimaging (2024). 2025; 15266:24-34.

PMID: 39872150 PMC: 11772010. DOI: 10.1007/978-3-031-78761-4_3.


Functional Connectivity Biomarkers in Schizophrenia.

Howell A, Anticevic A Adv Neurobiol. 2024; 40:237-283.

PMID: 39562448 DOI: 10.1007/978-3-031-69491-2_10.


Human brain state dynamics are highly reproducible and associated with neural and behavioral features.

Lee K, Ji J, Fonteneau C, Berkovitch L, Rahmati M, Pan L PLoS Biol. 2024; 22(9):e3002808.

PMID: 39316635 PMC: 11421804. DOI: 10.1371/journal.pbio.3002808.


Integration of estimated regional gene expression with neuroimaging and clinical phenotypes at biobank scale.

Hoang N, Sardaripour N, Ramey G, Schilling K, Liao E, Chen Y PLoS Biol. 2024; 22(9):e3002782.

PMID: 39269986 PMC: 11424006. DOI: 10.1371/journal.pbio.3002782.


A measure of reliability convergence to select and optimize cognitive tasks for individual differences research.

Kadlec J, Walsh C, Sade U, Amir A, Rissman J, Ramot M Commun Psychol. 2024; 2(1):64.

PMID: 39242856 PMC: 11332135. DOI: 10.1038/s44271-024-00114-4.


References
1.
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine D, Quinn K . Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010; 167(7):748-51. DOI: 10.1176/appi.ajp.2010.09091379. View

2.
Rosenberg M, Finn E, Scheinost D, Papademetris X, Shen X, Constable R . A neuromarker of sustained attention from whole-brain functional connectivity. Nat Neurosci. 2015; 19(1):165-71. PMC: 4696892. DOI: 10.1038/nn.4179. View

3.
Calhoun V, Kiehl K, Pearlson G . Modulation of temporally coherent brain networks estimated using ICA at rest and during cognitive tasks. Hum Brain Mapp. 2008; 29(7):828-38. PMC: 2649823. DOI: 10.1002/hbm.20581. View

4.
Shen X, Tokoglu F, Papademetris X, Constable R . Groupwise whole-brain parcellation from resting-state fMRI data for network node identification. Neuroimage. 2013; 82:403-15. PMC: 3759540. DOI: 10.1016/j.neuroimage.2013.05.081. View

5.
Keefe R, Bilder R, Davis S, Harvey P, Palmer B, Gold J . Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry. 2007; 64(6):633-47. DOI: 10.1001/archpsyc.64.6.633. View